Dry Powder Inhalers (DPIs) are employed to supply a safe dose of Active Pharmaceutical Ingredient (API) to the deep lung. Image Credit: Freeman Technology An excipient transports the delicate ...
FORT WORTH, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and ...
In the hunt for COVID-19 drugs, Gilead Sciences' remdesivir remains the sole pharma product authorized in the U.S. But it's reserved for hospitalized patients, leaving those with mild or moderate ...
LEXINGTON, Mass.--Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that its iSPERSE™ inhaled drug delivery platform demonstrated the ...
LOS ANGELES--(BUSINESS WIRE)--OtiTopic, Inc. today announced that the U.S. Patent and Trade Office (USPTO) has granted two new patents protecting intellectual property related to its lead candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback